Long-Term Peritoneal Dialysis May Result in Vascular Changes Within the Peritoneal Cavity, Leading to Reduced Efficacy of Intravenous Antibiotics in Treatment of Bacterial Peritonitis

Am J Med. 2017 Oct;130(10):e449-e450. doi: 10.1016/j.amjmed.2017.05.015. Epub 2017 Jun 7.

Authors

Hassan Bin Attique¹, Snehal Naik², Attiya Haroon³, Ruchir D Trivedi⁴

Affiliations

¹ Division of Nephrology, Department of Medicine, University of Connecticut, Farmington.
² Department of Medicine, University of Connecticut, Farmington.
³ Rutgers Robert Wood Johnson Medical School, Piscataway Township, NJ.
⁴ Division of Nephrology, Department of Medicine, University of Connecticut, Farmington. Electronic address: rtrivedi@uchc.edu.

PMID: 28601541
DOI: 10.1016/j.amjmed.2017.05.015

No abstract available

Publication types

Case Reports

MeSH terms

Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / therapeutic use*
Humans
Kidney Failure, Chronic / therapy*
Male
Middle Aged
Peritoneal Cavity / blood supply*
Peritoneal Cavity / pathology
Peritoneal Dialysis / adverse effects*
Peritonitis / drug therapy*
Time Factors

Substances

Anti-Bacterial Agents